Boosting Both Endocannabinoids Together Was Needed to Mimic THC's Subjective Effects in Rats
Neither anandamide nor 2-AG alone could fully replicate THC's discriminative stimulus effects in rats, but simultaneously elevating both endocannabinoids approached full substitution.
Quick Facts
What This Study Found
Mice and rats trained to discriminate THC from vehicle were tested with various endocannabinoid-enhancing strategies. Directly administering anandamide or 2-AG did not substitute for THC, even when combined with enzyme inhibitors. However, the FAAH inhibitor PF3845 enhanced anandamide's ability to produce THC-like effects in mice, and the MAGL inhibitor JZL184 increased THC-like responding on its own.
In rats, neither FAAH inhibition (URB597) nor MAGL inhibition (JZL184) alone produced significant THC-like effects. But combining both inhibitors approached full substitution for THC, suggesting that simultaneous elevation of both anandamide and 2-AG is necessary to replicate THC's subjective effects.
Species differences were notable: what worked in mice did not always work in rats, highlighting the importance of species selection in preclinical cannabinoid research.
Key Numbers
THC discrimination doses: 5.6 mg/kg (mice), 3 mg/kg (rats). FAAH inhibitor PF3845 enhanced anandamide substitution. MAGL inhibitor JZL184 increased THC-like responding. Combined FAAH+MAGL inhibition approached full substitution in rats.
How They Did This
Mice and rats were trained in a drug discrimination paradigm to distinguish THC from vehicle. Various combinations of exogenous endocannabinoids and enzyme inhibitors (FAAH and MAGL) were tested for their ability to substitute for THC. Brain endocannabinoid levels were measured after some treatments.
Why This Research Matters
Understanding which endocannabinoids contribute to THC's subjective effects helps explain why cannabis produces the specific psychoactive experience it does. The finding that both endocannabinoids are needed to replicate THC's effects reveals the complexity of the endocannabinoid system.
The Bigger Picture
THC activates CB1 receptors directly, but the subjective experience it produces depends on how it mimics or differs from natural endocannabinoid signaling. This study shows that replicating THC's full subjective profile requires elevating both major endocannabinoids simultaneously.
What This Study Doesn't Tell Us
Drug discrimination studies measure whether animals perceive a drug as "THC-like" but cannot directly measure subjective experience. Species differences between mice and rats complicate interpretation. The doses and routes of administration may not translate to human use.
Questions This Raises
- ?Would dual enzyme inhibition produce cannabis-like subjective effects in humans?
- ?Are there other endocannabinoid system components needed beyond anandamide and 2-AG?
- ?Could this information help develop non-psychoactive therapeutic cannabinoids?
Trust & Context
- Key Stat:
- Both endocannabinoids (anandamide + 2-AG) needed together to replicate THC's effects
- Evidence Grade:
- This is a preclinical pharmacology study providing mechanistic insight into endocannabinoid contributions to THC's effects.
- Study Age:
- Published in 2014. Drug discrimination remains an important tool for studying cannabinoid pharmacology.
- Original Title:
- Endocannabinoid contribution to Δ9-tetrahydrocannabinol discrimination in rodents.
- Published In:
- European journal of pharmacology, 737, 97-105 (2014)
- Authors:
- Wiley, Jenny L(13), Walentiny, D Matthew(3), Wright, M Jerry, Beardsley, Patrick M, Burston, James J, Poklis, Justin L, Lichtman, Aron H, Vann, Robert E
- Database ID:
- RTHC-00894
Evidence Hierarchy
Tests effects in animals (usually mice or rats), not humans.
What do these levels mean? →Frequently Asked Questions
What is drug discrimination?
Animals are trained to press one lever when they receive a drug (THC) and a different lever when they receive a placebo. Then researchers test whether other drugs produce the same internal sensation as THC, measured by which lever the animal chooses.
Why does this require both endocannabinoids?
Anandamide and 2-AG act through overlapping but distinct mechanisms. THC broadly activates CB1 receptors in a way that apparently mimics the combined effect of both endocannabinoids acting together, rather than either one alone.
Read More on RethinkTHC
- THC-amygdala-anxiety-brain
- anandamide-weed-withdrawal
- cannabinoid-receptors-recovery-time
- cannabis-developing-brain-teenagers
- cant-enjoy-anything-without-weed
- dopamine-recovery-after-quitting-weed
- endocannabinoid-system-explained-simply
- endocannabinoid-system-withdrawal
- nervous-system-weed-withdrawal-fight-flight
- teen-weed-use-under-18-effects-brain
- thc-brain-withdrawal
- thc-prefrontal-cortex-brain-effects
- weed-cortisol-stress-hormones
- weed-memory-loss-recovery
- weed-motivation-amotivational-syndrome
- weed-nervous-system-effects
- weed-reward-system-brain
Cite This Study
https://rethinkthc.com/research/RTHC-00894APA
Wiley, Jenny L; Walentiny, D Matthew; Wright, M Jerry; Beardsley, Patrick M; Burston, James J; Poklis, Justin L; Lichtman, Aron H; Vann, Robert E. (2014). Endocannabinoid contribution to Δ9-tetrahydrocannabinol discrimination in rodents.. European journal of pharmacology, 737, 97-105. https://doi.org/10.1016/j.ejphar.2014.05.013
MLA
Wiley, Jenny L, et al. "Endocannabinoid contribution to Δ9-tetrahydrocannabinol discrimination in rodents.." European journal of pharmacology, 2014. https://doi.org/10.1016/j.ejphar.2014.05.013
RethinkTHC
RethinkTHC Research Database. "Endocannabinoid contribution to Δ9-tetrahydrocannabinol disc..." RTHC-00894. Retrieved from https://rethinkthc.com/research/wiley-2014-endocannabinoid-contribution-to-9tetrahydrocannabinol
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkTHC research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.